Literature DB >> 29458219

Clinical, Endocrine and Imaging Characteristics of Patients with Primary Hypophysitis.

Anna Angelousi1, Carolina Cohen2, Soledad Sosa2, Karina Danilowicz2, Lina Papanastasiou3, Marina Tsoli1, Aparna Pal4, Georgios Piaditis3, Ashley Grossman4, Gregory Kaltsas1.   

Abstract

Primary hypophysitis (PH) is a rare disease with a poorly-defined natural history. Our aim was to characterise patients with PH at presentation and during prolonged follow-up. Observational retrospective study of 22 patients was conducted from 3 centres. In 14 patients, PH was confirmed histologically and in the remaining 8 clinically, after excluding secondary causes of hypophysitis. All patients had hormonal and imaging investigations before any treatment. Median follow up was 48 months (25-75%: 3-60). There was a female predominance with a female/male ratio: 3.4:1. Eight out of 22 patients had another autoimmune disease. Headaches and gonadal dysfunction were the most common symptoms. Five patients presented with panhypopituitarism; 17 patients had anterior pituitary deficiency, and 7 had diabetes insipidus. At presentation, 9 patients were treated surgically, 5 received replacement hormonal treatment, and 8 high-dose glucocorticoids from whom 5 in association with other immunosuppressive agents. Six patients showed complete recovery of pituitary hormonal deficiencies while 6 showed a partial recovery during a 5-year follow-up period. No difference was found between patients treated with surgery and those treated medically. The overall relapse rate was 18%. PH can be manifested with a broad spectrum of clinical and hormonal disturbances. Long-term follow-up is required to define the natural history of the disease and response to treatment, since pituitary hormonal recovery or relapse may appear many years after initial diagnosis. We suggest that surgery and immunosuppressive therapy be reserved for exceptional cases. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29458219     DOI: 10.1055/s-0044-101036

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  7 in total

Review 1.  Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Constantine A Stratakis; Christian A Koch
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Outcomes of Initial Management Strategies in Patients With Autoimmune Lymphocytic Hypophysitis: A Systematic Review and Meta-analysis.

Authors:  Diane Donegan; Zeb Saeed; Danae A Delivanis; Mohammad Hassan Murad; Juergen Honegger; Felix Amereller; Seda Hanife Oguz; Dana Erickson; Irina Bancos
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

3.  Neuro-radiological features can predict hypopituitarism in primary autoimmune hypophysitis.

Authors:  Tommaso Tartaglione; Sabrina Chiloiro; Maria Elena Laino; Antonella Giampietro; Simona Gaudino; Angelo Zoli; Antonio Bianchi; Alfredo Pontecorvi; Cesare Colosimo; Laura De Marinis
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

Review 4.  Insights into non-classic and emerging causes of hypopituitarism.

Authors:  Flavia Prodam; Marina Caputo; Chiara Mele; Paolo Marzullo; Gianluca Aimaretti
Journal:  Nat Rev Endocrinol       Date:  2020-11-27       Impact factor: 43.330

Review 5.  Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation.

Authors:  Sriram Gubbi; Fady Hannah-Shmouni; Joseph G Verbalis; Christian A Koch
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2019-12-12       Impact factor: 4.690

6.  Full recovery from chronic headache and hypopituitarism caused by lymphocytic hypophysitis: A case report.

Authors:  Mao-Guang Yang; Han-Qing Cai; Si-Si Wang; Lin Liu; Chun-Mei Wang
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

Review 7.  Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease.

Authors:  Fabienne Langlois; Elena V Varlamov; Maria Fleseriu
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.